HPRA Drug Safety Newsletter Edition 113

Download: hpra-drug-safety-newsletter-edition-113.pdf 629 KB

The latest edition of the HPRA Drug Safety Newsletter (DSN 113) includes important updates to support the safe and appropriate use of the following medicines:

  • Topiramate: Introduction of a pregnancy prevention programme and new restrictions on use
  • Valproate (Epilim): Ongoing review of potential risk of neurodevelopmental disorders in children of fathers treated with valproate in the three months prior to conception

« Back